Shellfish exoskeletons don’t usually have a place on the battlefield. But to Axio Bio­solutions, led by bioengineer Leo Mavely, they are essential ingredients for fast-acting wound care. From his own experience about two decades ago in Delhi, when he stepped in to help a hemorrhaging accident survivor, came the Axiostat bandage: the first Indian hemostatic product to receive 510(k) clearance from the U.S. Food and Drug Administration in 2018. Axiostat uses chitosan, derived from chitin in shrimp shells, to swiftly stop bleeding. Mavely says Axio’s product has been used across multiple scenarios, from road accidents to medical procedures, in…

Read the full article at TIME.COM